{"id":"https://openalex.org/W4200317543","doi":"https://doi.org/10.1016/j.euroneuro.2021.10.580","title":"P.0615 Biopsychosocial effect of the Covid-19 pandemic in patients under medication-assisted treatment with methadone and buprenorphine","display_name":"P.0615 Biopsychosocial effect of the Covid-19 pandemic in patients under medication-assisted treatment with methadone and buprenorphine","alternate_titles":[],"publication_year":2021,"publication_date":"2021-12-01","ids":{"openalex":"https://openalex.org/W4200317543","doi":"https://doi.org/10.1016/j.euroneuro.2021.10.580","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8716273"},"language":"en","primary_location":{"id":"doi:10.1016/j.euroneuro.2021.10.580","doi":"https://doi.org/10.1016/j.euroneuro.2021.10.580","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.euroneuro.2021.10.580","pdf_url":null,"source":{"id":"https://openalex.org/S168041952","display_name":"European Neuropsychopharmacology","issn_l":"0924-977X","issn":["0924-977X","1873-7862"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Neuropsychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4200317543"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8716273/pdf/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090517429","display_name":"Christonikos Leventelis","orcid":"https://orcid.org/0000-0002-5221-9210","observed_orcids":["https://orcid.org/0000-0002-5221-9210"]},"institutions":[{"id":"https://openalex.org/I158716096","display_name":"University of Peloponnese","ror":"https://ror.org/04d4d3c02","country_code":"GR","type":"education","lineage":["https://openalex.org/I158716096"]},{"id":"https://openalex.org/I4405271210","display_name":"Organisation Against Drugs","ror":"https://ror.org/0223a3n11","country_code":"GR","type":"government","lineage":["https://openalex.org/I4405271210"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"C. Leventelis","raw_affiliation_strings":["University of Peloponnese - Organisation against Drugs, Department of Nursing, Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Peloponnese - Organisation against Drugs, Department of Nursing, Athens, Greece","institution_ids":["https://openalex.org/I158716096","https://openalex.org/I4405271210"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081396935","display_name":"Alexandra Katsouli","orcid":"https://orcid.org/0000-0002-7026-5990","observed_orcids":["https://orcid.org/0000-0002-7026-5990"]},"institutions":[{"id":"https://openalex.org/I4405271210","display_name":"Organisation Against Drugs","ror":"https://ror.org/0223a3n11","country_code":"GR","type":"government","lineage":["https://openalex.org/I4405271210"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"A. Katsouli","raw_affiliation_strings":["Organisation against Drugs, Nursing, Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Organisation against Drugs, Nursing, Athens, Greece","institution_ids":["https://openalex.org/I4405271210"]}]},{"author_position":"middle","author":{"id":null,"display_name":"P. Papadopoulos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405271210","display_name":"Organisation Against Drugs","ror":"https://ror.org/0223a3n11","country_code":"GR","type":"government","lineage":["https://openalex.org/I4405271210"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"P. Papadopoulos","raw_affiliation_strings":["Organisation against Drugs, Nursing, Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Organisation against Drugs, Nursing, Athens, Greece","institution_ids":["https://openalex.org/I4405271210"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009047410","display_name":"V. Stauropoulos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405271210","display_name":"Organisation Against Drugs","ror":"https://ror.org/0223a3n11","country_code":"GR","type":"government","lineage":["https://openalex.org/I4405271210"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"V. Stauropoulos","raw_affiliation_strings":["Organisation against Drugs, Nursing, Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Organisation against Drugs, Nursing, Athens, Greece","institution_ids":["https://openalex.org/I4405271210"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022103981","display_name":"Anna Karasavvidou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405271210","display_name":"Organisation Against Drugs","ror":"https://ror.org/0223a3n11","country_code":"GR","type":"government","lineage":["https://openalex.org/I4405271210"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"A. Karasavidou","raw_affiliation_strings":["Organisation against Drugs, Nursing, Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Organisation against Drugs, Nursing, Athens, Greece","institution_ids":["https://openalex.org/I4405271210"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030204305","display_name":"E. Batsiari","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405271210","display_name":"Organisation Against Drugs","ror":"https://ror.org/0223a3n11","country_code":"GR","type":"government","lineage":["https://openalex.org/I4405271210"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"E. Batsiari","raw_affiliation_strings":["Organisation against Drugs, Psychology, Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Organisation against Drugs, Psychology, Athens, Greece","institution_ids":["https://openalex.org/I4405271210"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070595532","display_name":"Maria Tsironi","orcid":"https://orcid.org/0000-0002-0569-6217","observed_orcids":["https://orcid.org/0000-0002-0569-6217"]},"institutions":[{"id":"https://openalex.org/I158716096","display_name":"University of Peloponnese","ror":"https://ror.org/04d4d3c02","country_code":"GR","type":"education","lineage":["https://openalex.org/I158716096"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"M. Tsironi","raw_affiliation_strings":["University of Peloponnese, Department of Nursing, Tripoli, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Peloponnese, Department of Nursing, Tripoli, Greece","institution_ids":["https://openalex.org/I158716096"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":0.1969,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.4796949,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"53","issue":null,"first_page":"S452","last_page":"S452"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.5054000020027161,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.5054000020027161,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10168","display_name":"COVID-19 and Mental Health","score":0.4894999861717224,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.9890000224113464},{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.7609999775886536},{"id":"https://openalex.org/keywords/medication-assisted-treatment","display_name":"medication-assisted treatment","score":0.9100000262260437},{"id":"https://openalex.org/keywords/methadone","display_name":"methadone","score":0.9940000176429749},{"id":"https://openalex.org/keywords/buprenorphine","display_name":"buprenorphine","score":1.0},{"id":"https://openalex.org/keywords/biopsychosocial-effects","display_name":"biopsychosocial effects","score":0.8560000061988831}],"concepts":[{"id":"https://openalex.org/C2778949969","wikidata":"https://www.wikidata.org/wiki/Q407721","display_name":"Buprenorphine","level":4,"score":0.8974968791007996},{"id":"https://openalex.org/C2778767360","wikidata":"https://www.wikidata.org/wiki/Q179996","display_name":"Methadone","level":2,"score":0.8550399541854858},{"id":"https://openalex.org/C137886200","wikidata":"https://www.wikidata.org/wiki/Q2725568","display_name":"Biopsychosocial model","level":2,"score":0.8149958848953247},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.661564826965332},{"id":"https://openalex.org/C89623803","wikidata":"https://www.wikidata.org/wiki/Q12184","display_name":"Pandemic","level":5,"score":0.6461087465286255},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6395729184150696},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37180620431900024},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3491952121257782},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.332755982875824},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.31795939803123474},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.26157307624816895},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.255829393863678},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.04481056332588196},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1016/j.euroneuro.2021.10.580","doi":"https://doi.org/10.1016/j.euroneuro.2021.10.580","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.euroneuro.2021.10.580","pdf_url":null,"source":{"id":"https://openalex.org/S168041952","display_name":"European Neuropsychopharmacology","issn_l":"0924-977X","issn":["0924-977X","1873-7862"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Neuropsychopharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8716273","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8716273/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8716273/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Eur Neuropsychopharmacol","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:8716273","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8716273/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8716273/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Eur Neuropsychopharmacol","raw_type":"Text"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4200317543.pdf","grobid_xml":"https://content.openalex.org/works/W4200317543.grobid-xml"},"referenced_works_count":4,"referenced_works":["https://openalex.org/W2019653257","https://openalex.org/W2283026346","https://openalex.org/W3010466793","https://openalex.org/W3018494531"],"related_works":["https://openalex.org/W3015719723","https://openalex.org/W2091217598","https://openalex.org/W4200077283","https://openalex.org/W1983114669","https://openalex.org/W2514617099","https://openalex.org/W4394771769","https://openalex.org/W4200313436","https://openalex.org/W3016456878","https://openalex.org/W4412784200","https://openalex.org/W4200383959"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4200317543","counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2021-12-31T00:00:00"}
